E. Keystone

467 total citations
26 papers, 357 citations indexed

About

E. Keystone is a scholar working on Rheumatology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, E. Keystone has authored 26 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 12 papers in Genetics and 6 papers in Pathology and Forensic Medicine. Recurrent topics in E. Keystone's work include Rheumatoid Arthritis Research and Therapies (18 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Systemic Lupus Erythematosus Research (6 papers). E. Keystone is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (18 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Systemic Lupus Erythematosus Research (6 papers). E. Keystone collaborates with scholars based in Canada, United States and United Kingdom. E. Keystone's co-authors include Axel Finckh, Carine Salliot, Yan Lü, Ye Sun, Wanruchada Katchamart, Claire Bombardier, Roy Fleischmann, Michael E. Weinblatt, Piet L. C. M. van Riel and Josef S Smolen and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and The Journal of Rheumatology.

In The Last Decade

E. Keystone

25 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Keystone Canada 8 259 108 86 70 59 26 357
Ravi Rao United Kingdom 5 184 0.7× 66 0.6× 109 1.3× 58 0.8× 102 1.7× 8 336
Gudrun Reynisdottir Sweden 6 347 1.3× 52 0.5× 114 1.3× 59 0.8× 29 0.5× 12 563
Valérie Badot Belgium 12 221 0.9× 57 0.5× 142 1.7× 104 1.5× 20 0.3× 26 413
Ann Igoe United States 6 162 0.6× 70 0.6× 110 1.3× 42 0.6× 33 0.6× 7 307
Jeffrey Box United States 3 336 1.3× 177 1.6× 137 1.6× 58 0.8× 112 1.9× 5 445
Ayanbola Elegbe United States 8 308 1.2× 142 1.3× 116 1.3× 80 1.1× 104 1.8× 22 424
M. Safy Netherlands 7 240 0.9× 64 0.6× 149 1.7× 38 0.5× 49 0.8× 10 375
Е. П. Иливанова Russia 6 356 1.4× 167 1.5× 186 2.2× 51 0.7× 79 1.3× 21 448
Andrew Chubick United States 6 269 1.0× 104 1.0× 154 1.8× 127 1.8× 143 2.4× 8 456
Victoria Bejarano United Kingdom 9 469 1.8× 197 1.8× 256 3.0× 43 0.6× 87 1.5× 10 650

Countries citing papers authored by E. Keystone

Since Specialization
Citations

This map shows the geographic impact of E. Keystone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Keystone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Keystone more than expected).

Fields of papers citing papers by E. Keystone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Keystone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Keystone. The network helps show where E. Keystone may publish in the future.

Co-authorship network of co-authors of E. Keystone

This figure shows the co-authorship network connecting the top 25 collaborators of E. Keystone. A scholar is included among the top collaborators of E. Keystone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Keystone. E. Keystone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keystone, E., et al.. (2017). SAT0155 Adalimumab in combination with non-methotrexate conventional synthetic disease modifying rheumatic drugs in a clinical trial setting. Annals of the Rheumatic Diseases. 76. 828–828. 1 indexed citations
2.
3.
4.
Barnabé, Cheryl, Yangbo Sun, Gilles Boire, et al.. (2015). Sociodemographic and Health Status Characteristics Explain Five Clinical Outcome and Radiographic Trajectories in Early Rheumatoid Arthritis: Data from the CATCH Cohort. The Journal of Rheumatology. 42(7). 1277–1277. 1 indexed citations
5.
Taylor, Paul C.J., M. C. Genovese, E. Keystone, et al.. (2015). THU0175 Effects of Baricitinib on Multibiomarker Disease Activity Scores and Their Components in a Phase 2B Study in Moderate-to-Severe Rheumatoid Arthritis Patients. Annals of the Rheumatic Diseases. 74. 257–258. 1 indexed citations
6.
Visser, K., Susan J. Bartlett, Juan Xiong, et al.. (2013). Changes In Patient-Reported Joint Counts and Composite Indices Can Identify Flare Of Disease Activity In Recent Onset Rheumatoid Arthritis. Data Archiving and Networked Services (DANS). 65. 2 indexed citations
7.
Vollenhoven, Ronald van, Paul Emery, Clifton O. Bingham, et al.. (2013). SAT0131 Long-Term Safety of Rituximab: Pooled Analysis of the Rheumatoid Arthritis Global Clinical Trial Programme Over 11 Years. Annals of the Rheumatic Diseases. 72. A625–A626. 2 indexed citations
8.
9.
Keystone, E., Josef S Smolen, & Piet L. C. M. van Riel. (2012). Developing an effective treatment algorithm for rheumatoid arthritis. Lara D. Veeken. 51(suppl 5). v48–v54. 28 indexed citations
10.
Haraoui, Boulos, et al.. (2012). SAT0084 Effects of different steroid doses on adverse events and radiographic progression of certolizumab pegol-treated rheumatoid arthritis patients. Annals of the Rheumatic Diseases. 71. 498–498. 5 indexed citations
11.
12.
Landewé, R., et al.. (2011). JOINT SPACE NARROWING HAS A STRONGER IMPACT ON PHYSICAL FUNCTION THAN JOINT EROSION: RESULTS FROM EIGHT YEAR LONGITUDINAL ANALYSES. Lara D. Veeken. 50. 119–119. 5 indexed citations
13.
Keystone, E., R. Fleischmann, J S Smolen, et al.. (2010). THE EFFICACY OF CERTOLIZUMAB PEGOL ADDED TO METHOTREXATE IS SUSTAINED OVER 2 YEARS IN THE TREATMENT OF RHEUMATOID ARTHRITIS. Lara D. Veeken. 49. 1 indexed citations
14.
15.
Furst, D E, F C Breedveld, J. R. Kalden, et al.. (2007). Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007. Annals of the Rheumatic Diseases. 66. iii2–iii22. 115 indexed citations
16.
Keystone, E.. (2005). Safety issues related to emerging therapies for rheumatoid arthritis.. PubMed. 22(5 Suppl 35). S148–50. 7 indexed citations
17.
Hua, Fei, et al.. (1993). Are Antibodies Reactive with Chondrocyte Proteins Enriched in Synovial Fluids of Patients with Rheumatoid Arthritis?. Birkhäuser Basel eBooks. 39. 81–86. 1 indexed citations
18.
Khraishi, Majed, Venita Jay, & E. Keystone. (1992). Inclusion body myositis in association with vitamin B12 deficiency and Sjögren's syndrome.. PubMed. 19(2). 306–9. 12 indexed citations
19.
Keystone, E., et al.. (1991). Polymyositis associated with primary biliary cirrhosis.. PubMed. 18(11). 1767–8. 10 indexed citations
20.
Lee, Peter, et al.. (1986). Digital blood flow and nailfold capillary microscopy in Raynaud's phenomenon.. PubMed. 13(3). 564–9. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ravi Rao Breakdown of academic impact, for papers by Gudrun Reynisdottir Breakdown of academic impact, for papers by Valérie Badot Breakdown of academic impact, for papers by Ann Igoe Breakdown of academic impact, for papers by Jeffrey Box Breakdown of academic impact, for papers by Ayanbola Elegbe Breakdown of academic impact, for papers by M. Safy Breakdown of academic impact, for papers by Е. П. Иливанова Breakdown of academic impact, for papers by Andrew Chubick Breakdown of academic impact, for papers by Victoria Bejarano
Rankless by CCL
2026